Three doses of the Pfizer BioNTech COVID 19 vaccine offer significant levels of protection against the highly infectious new coronavirus variant, Omicron.
That’s according to the companies’ latest research, which reveals a 25-fold reduction in antibody levels against the new strain, among individuals who had only had two doses.
Nina-Maria Potts has more:
IN: “ The blood…
OUT: SOC
DUR: 45 seconds